The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature von Rier, Hánah N., Jager, Agnes, Sleijfer, Stefan, Maier, Andrea B., Levin, Mark‐David

Volltext

Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy von Rier, Hánah N, Jager, Agnes, Sleijfer, Stefan, van Rosmalen, Joost, Kock, Marc C.J.M, Levin, Mark-David

Volltext

Sarcopenia & aging in cancer von Williams, Grant R., Rier, Hánah N., McDonald, Andrew, Shachar, Shlomit S.

Volltext

Association Between Geriatric Assessment and Post-Chemotherapy Functional Status in Older Patients with Cancer von Rier, Hánah N, Meinardi, Marieke C, van Rosmalen, Joost, Westerweel, Peter E, de Jongh, Eva, Kitzen, Jos J E M, van den Bosch, Joan, Trajkovic, Marija, Levin, Mark-David

Volltext

Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer von Rier, Hánah N., Jager, Agnes, Sleijfer, Stefan, van Rosmalen, Joost, Kock, Marc C. J. M., Levin, Mark-David

Volltext

The effect of trastuzumab on cardiac function in patients with HER2‐positive metastatic breast cancer and reduced baseline left ventricular ejection fraction von Bouwer, Nathalie I., Steenbruggen, Tessa G., Rier, Hánah N., Kitzen, Jos J. E. M., Smorenburg, Carolien H., Bekkum, Marlies L., Jong, Paul C., Drooger, Jan C., Holterhues, Cynthia, Kofflard, Marcel J. M., Boersma, Eric, Sonke, Gabe S., Levin, Mark‐David, Jager, Agnes

Volltext

Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatment von Rier, Hánah N., Jager, Agnes, Meinardi, Marieke C., van Rosmalen, Joost, Kock, Marc C. J. M., Westerweel, Peter E., Trajkovic, Marija, Sleijfer, Stefan, Levin, Mark-David

Volltext

The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients von van Doorn, Leni, Crombag, Marie-Rose B. S., Rier, Hanah N., van Vugt, Jeroen L. A., van Kesteren, Charlotte, Bins, Sander, Mathijssen, Ron H. J., Levin, Mark-David, Koolen, Stijn L. W.

Volltext

First‐Line Palliative HER2‐Targeted Therapy in HER2‐Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab‐Based Therapy von Rier, Hánah N., Levin, Mark‐David, van Rosmalen, Joost, Bos, Monique M. E. M., Drooger, Jan C., de Jong, Paul, Portielje, Johanneke E. A., Elsten, Elisabeth M. P., Ten Tije, Albert‐Jan, Sleijfer, Stefan, Jager, Agnes

Volltext

Abstract PS13-21: Cardiac function in patients receiving trastuzumab for HER2+ metastatic breast cancer with left ventricular ejection fraction<50% at baseline von Bouwer, Nathalie I, Steenbruggen, Tessa G, Rier, Hanah N, Kitzen, Jos JEM, Smorenburg, Carolien H, Van Bekkum, Marlies L, Tije, Albert J Ten, De Jong, Paul C, Drooger, Jan C, Holterhues, Cynthia, Kofflard, Marcel JM, Boersma, Eric, Sonke, Gabe S, Levin, Mark-David, Jager, Agnes

Volltext